kabutan

Premier Anti-Aging, First Half Ordinary Profit Turns to Profit, Exceeds Expectations, Exceeds Full-Year Plan

Thu Mar 13, 2025 3:30 pm JST Earnings

4934 Premier Anti-Aging Co.,Ltd. 【J-GAAP】

Earnings Report

Premier Anti-Aging Co.,Ltd. <4934> [TSE Growth] announced its financial results after the market closed on March 13th (15:30). The consolidated ordinary profit/loss for the cumulative second quarter of the fiscal year ending July 2025 (August 2024 to January 2025) turned into a profit of 970 million yen (compared to a loss of 199 million yen in the same period last year), reversing from the forecast of a loss of 160 million yen to a profit.

The progress rate toward the full-year plan of 130 million yen is 746.2%.

Based on the first-half performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit/loss for the February to July period (2H) is expected to turn into a loss of 840 million yen (compared to a profit of 360 million yen in the same period last year).

In the most recent three-month period, from November to January (2Q), the consolidated ordinary profit/loss turned to a profit of 345 million yen (compared to a loss of 173 million yen in the same period last year). The operating profit/loss margin drastically improved from -3.2% in the same period last year to 8.3%.

Kabutan News

Actual Results

Accumulated Results 2nd Quarter
Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Progress Rate vs. First Half Announce Accounting Standards
Aug - Jan, 2022 14,258 109 95 -26 -3.0 Mar 14, 2023 J-GAAP
Aug - Jan, 2023 10,649 -205 -199 -1,685 -193.3 Mar 14, 2024 J-GAAP
Aug - Jan, 2024 8,528 977 970 581 66.7 746.2 Mar 13, 2025 J-GAAP
YoY -19.9%

First Half Results vs. Previous Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Aug - Jan, 2024 Guidance 8,500 -150 -160 -160 -18.4 0 Sep 12, 2024 J-GAAP
Aug - Jan, 2024 Results 8,528 977 970 581 66.7 0 Mar 13, 2025 J-GAAP
Revision Rate +0.3%

Current Period Guidance

Second Half Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Feb - Jul, 2024 9,710 344 360 202 23.2 0 Sep 12, 2024 J-GAAP
Feb - Jul, 2025 Guidance 8,972 -827 -840 -451 -51.7 0 Mar 13, 2025 J-GAAP
YoY -7.6%

Current Period Guidance

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Adj. Dividend Announce Accounting Standards
Jul, 2023 26,400 -611 -631 -733 -84.2 0 Sep 14, 2023 J-GAAP
Jul, 2024 20,359 139 161 -1,483 -170.1 0 Sep 12, 2024 J-GAAP
Jul, 2025 Guidance 17,500 150 130 130 14.9 0 Sep 12, 2024 J-GAAP
YoY -14.0% +7.9% -19.3%

Quarterly Results

Fiscal Year Revenue Operating Profit Ordinary Profit Net Profit Adj. EPS Operating Profit Margin Announce Accounting Standards
Nov - Jan, 2023 5,385 -170 -173 -1,650 -189.2 -3.2 Mar 14, 2024 J-GAAP
Feb - Apr, 2024 4,790 208 243 235 27.0 4.3 Jun 13, 2024 J-GAAP
May - Jul, 2024 4,920 136 117 -33 -3.8 2.8 Sep 12, 2024 J-GAAP
Aug - Oct, 2024 4,230 622 625 414 47.5 14.7 Dec 13, 2024 J-GAAP
Nov - Jan, 2024 4,298 355 345 167 19.2 8.3 Mar 13, 2025 J-GAAP
YoY -20.2%

Related Articles